FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lidocaine HCl Topical Jelly
Status: Discontinuation
»Therapeutic Categories: Anesthesia

Expand all

Teva Pharmaceuticals (New 04/27/2018)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 5 mL (NDC 0591-3012-26) 04/27/2018 This was a business-related decision to discontinue manufacturing these products
Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 30 mL (NDC 0591-3012-30) 04/27/2018 This was a business-related decision to discontinue manufacturing these products

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English